Literature DB >> 7673226

Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins.

L Berthiaume1, M D Resh.   

Abstract

Dynamic regulation of signal transduction by reversible palmitoylation-depalmitoylation cycles has been recently described. However, further understanding of fatty acylation reactions has been hampered by our lack of knowledge about the specific transferases and thioesterases involved. Here, we describe an assay for the palmitoyl acyltransferase (PAT) that palmitoylates "myrGlyCys" containing members of the Src family of protein tyrosine kinases (PTKs). Since N-myristoylation of Fyn PTK, a member of the Src family, has been shown to be a prerequisite for palmitolylation, a new single plasmid vector that allows overexpression of myristoylated Fyn substrate in Escherichia coli was developed. Purified myristoylated protein substrates were incubated with [125I]iodopalmitoyl CoA, a palmitoyl CoA analog, in the presence of bovine brain lysates. Transfer of radiolabel to the Fyn substrate was detected by SDS-polyacrylamide gel electrophoresis and autoradiography. This assay was used to partially purify and characterize PAT activity from bovine brain. Here, we demonstrate that PAT is a membrane-bound enzyme, which palmitoylates myristoylated Fyn substrates containing a cysteine residue in position three. The PAT activity attached palmitate to Fyn proteins via a thioester linkage and exhibited a fatty acyl CoA preference for long chain fatty acids. It is likely that palmitoylation of Fyn and other Src family members by PAT regulates PTK localization and signaling functions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7673226     DOI: 10.1074/jbc.270.38.22399

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Functional roles for fatty acylated amino-terminal domains in subcellular localization.

Authors:  J B McCabe; L G Berthiaume
Journal:  Mol Biol Cell       Date:  1999-11       Impact factor: 4.138

2.  Oxidative stress inhibits caveolin-1 palmitoylation and trafficking in endothelial cells.

Authors:  Marie-Odile Parat; Rafal Z Stachowicz; Paul L Fox
Journal:  Biochem J       Date:  2002-02-01       Impact factor: 3.857

3.  Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.

Authors:  S S Chen; S F Lee; C T Wang
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

4.  Vac8p release from the SNARE complex and its palmitoylation are coupled and essential for vacuole fusion.

Authors:  M Veit; R Laage; L Dietrich; L Wang; C Ungermann
Journal:  EMBO J       Date:  2001-06-15       Impact factor: 11.598

5.  The gamma2 subunit of GABA(A) receptors is a substrate for palmitoylation by GODZ.

Authors:  Cheryl A Keller; Xu Yuan; Patrizia Panzanelli; Michelle L Martin; Melissa Alldred; Marco Sassoè-Pognetto; Bernhard Lüscher
Journal:  J Neurosci       Date:  2004-06-30       Impact factor: 6.167

6.  Swf1-dependent palmitoylation of the SNARE Tlg1 prevents its ubiquitination and degradation.

Authors:  Javier Valdez-Taubas; Hugh Pelham
Journal:  EMBO J       Date:  2005-06-23       Impact factor: 11.598

7.  Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association.

Authors:  A Wolven; H Okamura; Y Rosenblatt; M D Resh
Journal:  Mol Biol Cell       Date:  1997-06       Impact factor: 4.138

8.  Pseudo-enzymatic S-acylation of a myristoylated yes protein tyrosine kinase peptide in vitro may reflect non-enzymatic S-acylation in vivo.

Authors:  M C Bañó; C S Jackson; A I Magee
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

9.  Galpha(s) is palmitoylated at the N-terminal glycine.

Authors:  Christiane Kleuss; Eberhard Krause
Journal:  EMBO J       Date:  2003-02-17       Impact factor: 11.598

10.  Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA.

Authors:  L Hermida-Matsumoto; M D Resh
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.